Nephrology News

President Donald Trump signed an Executive Order today to launch Advancing American Kidney Health, a new initiative to increase earlier intervention in CKD, incentivize dialysis providers to direct more patients to home dialysis and increase the number of kidneys available for transplantation.

The California Senate Health Committee approved a bill on July 3 that would limit how much dialysis providers could charge private health plans if patients received premium assistance from groups like the American Kidney Fund.

Considering urological diseases — prevalent in patients with CKD but frequently undiagnosed — during kidney disease assessments could help prevent the onset of CKD or slow the progression to ESKD, according to a published study.

Recently published findings suggest that participants in randomized clinical trials have significantly different characteristics, comorbidities and outcomes than patients with ESKD in the general population.

The success of cardiovascular therapies, whether medical or surgical, can be influenced by a CKD patient’s level of risk at baseline for cardiovascular disease, researchers concluded in a recent study.

Surveyed patients undergoing dialysis were either uncertain or overly optimistic about their prognosis, frequently estimating life expectancy to be longer than is likely, according to a recently published study.

A study on deceased donor kidneys has identified hepatitis C viremia, the need for dialysis, hematopoietic cell transplant and exposure to antibiotics with a narrow gramnegative spectrum as the top risks for infection.

Patients with gout have an increased risk for death from certain noncardiovascular conditions, particularly renal disease and diseases of the digestive system, according to data published in Arthritis & Rheumatology.

A single dose of sodium polystyrene sulfonate decreased serum potassium levels in patients with both chronic kidney disease and ESKD, potentially providing an effective treatment for hyperkalemia in this patient population, according to a published study.

For patients with chronic kidney disease, treatment of metabolic acidosis with oral alkali supplementation or a reduction in dietary acid intake may slow the rate of kidney function decline, thus reducing the risk for ESKD, according to systematic review and meta-analysis of clinical trials.